Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2013 Nov 1.

Published in final edited form as: Cancer. 2012 Apr 19;118(21):5384–5394. doi: 10.1002/cncr.27538

Kaplan-Meier estimates for serum autoantibody levels <4^th quartile (<Q4) versus 4^th quartile (Q4) for CTDSP1, MAPK9 and NR2E3, plotted as survival probability (y-axis) versus survival in days (x-axis). A. Grouped serum autoantibody levels within localized disease. B. Grouped serum autoantibody levels among surgical resection patients.

Kaplan-Meier estimates for serum autoantibody levels <4^th quartile (<Q4) versus 4^th quartile (Q4) for CTDSP1, MAPK9 and NR2E3, plotted as survival probability (y-axis) versus survival in days (x-axis). A. Grouped serum autoantibody levels within localized disease. B. Grouped serum autoantibody levels among surgical resection patients.